论文｜Jingyi Xu, Zhongxuan Liu, Jiayou Shi, Yue Wang, How Should China Set Ethical Guardrails for Medical Research?

本文（How Should China Set Ethical Guardrails for Medical Research? ）原载Journal of Medical Ethics，由四川大学法学院助理研究员刘忠炫等科研人员创作，系四川大学智慧法治超前部署学科系列学术成果。后续会持续分享四川大学智慧法治超前部署学科系列学术成果，欢迎大家阅读。

Abstract:“Ethics first” reform in China significantly changes the governance framework for the research of emerging technologies. The misapplicati on of human genome editing technology reflects the urgent need to reform the governance framework. Strengthening ethics governance in science and technology has become a consensus in China, where legal and ethical reforms areproceeding in parallel. The protection of human dignity, the prevention of biosafety risks, as well as the regulation of technological crimes are at the core of the legal system, which has been embodied in numerous fundamental legislations following the CRISPR-babies incident. Establishing a national ethics committee to coordinate ethics governance, and reinforcing ethics review and external oversight are significant steps in ethical reform. Essentially, ethics governance requires implementing the basic concept of “ethics first”, focusing onforward-looking and preventive governance rather than delayed intervention, while maintaining openness and collaboration.

Jingyi Xu, Zhongxuan Liu, Jiayou Shi, Yue Wang, How Should China Set Ethical Guardrails for Medical Research? Journal of Medical Ethics, Accepted 2 December 2023, doi:10.1136/jme-2023-109621.（论文下载）